Multi-million dollar machines promise bright future for medical research

Flow cytometry is taking medical research by storm. The versatility of its applications is taking scientists into unfounded territory.

In 2005, the Centenary Institute purchased three new machines to upgrade its multi-million dollar flow cytometry facility. This sophisticated equipment offers Centenary researchers a facility with a functional capacity unsurpassed by any other medical research facility in Australia.

Flow cytometry uses laser beams and advanced optics and electronics to count, analyse and purify many kinds of cells that make up tissues in humans and animals to help scientists gain a better understanding of their functions.

Dr. Adrian Smith, manager of Centenary's Flow Cytometry Facility said, "The demands placed on the facility by the rapid developments in our research have often exceeded the capabilities of existing instruments.

"The new machines offer our researchers unrivalled access to state-of-the-art equipment with very wide-ranging applications, driving them to produce work which pushes the boundaries of our current understanding of biological and disease processes."

With the capacity to accurately analyse and purify in excess of 25,000 cells every second, this technology is able to produce results that cannot be obtained by any other method.

At the Centenary Institute, flow cytometry is used on a daily basis to isolate very rare cells, study DNA content in cells, the production of biological agents called cytokines and chemokines, the expression of certain genes, the properties of dying cells and the different stages of cell development.

"Since the installation of the new machines, Centenary researchers have identified new cell populations which play a vital role in diseases such as diabetes, asthma, cancer and inflammatory bowel disease," Dr. Smith said.

"We are also using the machines to study responses to tuberculosis vaccines, as well as in myeloma research to monitor residual

Contact: Pearly Harumal
Research Australia

Page: 1 2

Related biology news :

1. Multi-million pound UK Biobank underway
2. Multi-million dollar deal to benefit medical research
3. Rutgers, Penn researchers capture research dollars to improve prostate cancer diagnostic methods
4. Yales Strobel named million-dollar professor for science teaching innovation
5. UC Davis external funding passes half billion dollars
6. TGen and NAU awarded multi-million dollar grant to identify genetic signatures of pathogens
7. OneWorld Health receives multimillion dollar grant for next steps in control of deadly disease
8. Tiny particles could solve billion-dollar problem
9. National Academy of Engineering announces million-dollar challenge to provide safe drinking water
10. Cranfield collaborator receives multi million dollar financing
11. Nanogenerators may spark miniature machines

Post Your Comments:

(Date:7/1/2020)... ... July 01, 2020 , ... ... had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in ... Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
(Date:6/23/2020)... MILTON KEYNES, England (PRWEB) , ... June 23, ... ... operations in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and ... rapid response project to support testing operations in the fight against the COVID-19 ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... SOUTH RIDING, Va. (PRWEB) , ... September 01, ... ... search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement ... Technologies . Averill will be responsible for leading all financial operations and implementing ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... 29, 2020 , ... eSource has long been touted as the solution to ... of eSource, the reasons it did not take off as quickly as people initially ... industry is moving towards capturing data electronically for clinical trials and then repurposing it ...
Breaking Biology Technology:
Cached News: